SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets)

SARS-CoV2 (COVID-19) Seroepidemiological Investigation in Transplanted Population Subjects of Kidney, Kidney-pancreas, Isolated Pancreas, Langerhans Islets

Evaluate SARS-CoV2 infection and the degree of immunity possibly developed in transplanted population using the Luciferase Immuno Precipitation System (LIPS) test.

Inclusion Criteria Cohort 1:

• Adult patients (age ≥ 18 years),
• Kidney or pancreas or pancreatic islets transplantation
• Transplanted patients (period: 01.01.2020 to 30.06.2020)
• Informed Consent signed

Inclusion Criteria Cohort 2:

• Adult patients (age ≥ 18 years),
• Kidney or pancreas or pancreatic islets transplantation
• transplanted patients in follow-up since 01.01.2020 or trasplanted patients after 30.06.2020.
• Informed Consent signed

Exclusion Criteria both Cohort (1&2):

Symptomatology such as fever> 37.5, and / or cough and / or respiratory distress and / or diarrhea / vomiting in 14 days prior to collection of blood sample